A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/704 (2006.01) A61K 31/7048 (2006.01) A61P 9/00 (2006.01) A61P 35/00 (2006.01) A61P 37/00 (2006.01)
Patent
CA 2614102
A method of treating a subject in need of therapy for a condition involving detrimental activity of the enzyme core 2 GIcNAc-T is provided, comprising administration of a therapeutically effective amount of an inhibitor of core 2 GIcNAc-T of formula (I) to a patient in need thereof wherein: R1 is H, C1-6 alkyl, C1-6 hydroxyalkyl, C1-6- alkoxy or C1-6 -alkoxy- C1-6-alkyl; R2 is H, - OH or C1-6 alkoxy; S1 and S2 are independently selected saccharide moieties; and Z is a steroid moiety; or a pharmaceutically acceptable salt, ether or ester thereof.
L'invention concerne un procédé permettant de traiter un patient nécessitant une thérapie d'un état impliquant une activité préjudiciable de l'enzyme GlcNAc-T de structure noyau 2, qui consiste à administrer au patient en question une dose thérapeutiquement efficace d'un inhibiteur de la GlcNAc-T de structure noyau 2 de la formule I, dans laquelle R1 représente H, C1-6alkyle, C1-6 hydroxyalkyle, C1-6- alcoxy ou C1-6 -alcoxy- C1-6-alkyle; R2 représente H, -OH ou C1-6 alcoxy; S1 et S2 sont des fragments de saccharide indépendamment choisis; et Z représente un fragment stéroïde; ou un sel, éther ou ester de celui-ci pharmaceutiquement acceptable.
Chibber Rakesh
Hagan Russell
Btg International Limited
Fetherstonhaugh & Co.
LandOfFree
Core 2 glcnac-t inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Core 2 glcnac-t inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Core 2 glcnac-t inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1697256